vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Federal Realty Investment Trust (FRT). Click either name above to swap in a different company.
Federal Realty Investment Trust is the larger business by last-quarter revenue ($336.0M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). Federal Realty Investment Trust runs the higher net margin — 38.6% vs 8.3%, a 30.4% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 8.7%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 6.5%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Federal Realty Investment Trust is a real estate investment trust that invests in shopping centers in the Northeastern United States, the Mid-Atlantic states, California, and South Florida.
COLL vs FRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $336.0M |
| Net Profit | $17.0M | $129.7M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | 53.8% |
| Net Margin | 8.3% | 38.6% |
| Revenue YoY | 12.9% | 8.7% |
| Net Profit YoY | 35.3% | 103.5% |
| EPS (diluted) | $0.48 | $1.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $336.0M | ||
| Q4 25 | $205.4M | $336.0M | ||
| Q3 25 | $209.4M | $322.3M | ||
| Q2 25 | $188.0M | $311.5M | ||
| Q1 25 | $177.8M | $309.2M | ||
| Q4 24 | $181.9M | $311.4M | ||
| Q3 24 | $159.3M | $303.6M | ||
| Q2 24 | $145.3M | $296.1M |
| Q1 26 | — | $129.7M | ||
| Q4 25 | $17.0M | $129.7M | ||
| Q3 25 | $31.5M | $61.6M | ||
| Q2 25 | $12.0M | $155.9M | ||
| Q1 25 | $2.4M | $63.8M | ||
| Q4 24 | $12.5M | $65.5M | ||
| Q3 24 | $9.3M | $61.0M | ||
| Q2 24 | $19.6M | $112.0M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | 53.8% | ||
| Q4 25 | 29.6% | 53.8% | ||
| Q3 25 | 29.7% | 34.3% | ||
| Q2 25 | 18.7% | 65.1% | ||
| Q1 25 | 12.2% | 35.0% | ||
| Q4 24 | 20.9% | 35.1% | ||
| Q3 24 | 21.9% | 34.9% | ||
| Q2 24 | 32.7% | 53.0% |
| Q1 26 | — | 38.6% | ||
| Q4 25 | 8.3% | 38.6% | ||
| Q3 25 | 15.0% | 19.1% | ||
| Q2 25 | 6.4% | 50.0% | ||
| Q1 25 | 1.4% | 20.6% | ||
| Q4 24 | 6.9% | 21.0% | ||
| Q3 24 | 5.9% | 20.1% | ||
| Q2 24 | 13.5% | 37.8% |
| Q1 26 | — | $1.49 | ||
| Q4 25 | $0.48 | $1.49 | ||
| Q3 25 | $0.84 | $0.69 | ||
| Q2 25 | $0.34 | $1.78 | ||
| Q1 25 | $0.07 | $0.72 | ||
| Q4 24 | $0.36 | $0.74 | ||
| Q3 24 | $0.27 | $0.70 | ||
| Q2 24 | $0.52 | $1.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $107.4M |
| Total DebtLower is stronger | — | $5.0B |
| Stockholders' EquityBook value | $301.7M | $3.2B |
| Total Assets | $1.7B | $9.1B |
| Debt / EquityLower = less leverage | — | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $107.4M | ||
| Q4 25 | $386.7M | $107.4M | ||
| Q3 25 | $285.9M | $111.3M | ||
| Q2 25 | $222.2M | $177.0M | ||
| Q1 25 | $197.8M | $109.2M | ||
| Q4 24 | $162.8M | $123.4M | ||
| Q3 24 | $120.0M | $97.0M | ||
| Q2 24 | $271.6M | $103.2M |
| Q1 26 | — | $5.0B | ||
| Q4 25 | — | $5.0B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $3.2B | ||
| Q4 25 | $301.7M | $3.2B | ||
| Q3 25 | $274.8M | $3.2B | ||
| Q2 25 | $232.2M | $3.2B | ||
| Q1 25 | $234.4M | $3.2B | ||
| Q4 24 | $228.8M | $3.2B | ||
| Q3 24 | $234.3M | $3.1B | ||
| Q2 24 | $216.6M | $3.0B |
| Q1 26 | — | $9.1B | ||
| Q4 25 | $1.7B | $9.1B | ||
| Q3 25 | $1.6B | $8.9B | ||
| Q2 25 | $1.6B | $8.6B | ||
| Q1 25 | $1.6B | $8.6B | ||
| Q4 24 | $1.7B | $8.5B | ||
| Q3 24 | $1.6B | $8.5B | ||
| Q2 24 | $1.1B | $8.4B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | — | 1.53× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.42× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $622.4M | ||
| Q3 25 | $78.4M | $147.8M | ||
| Q2 25 | $72.4M | $150.7M | ||
| Q1 25 | $55.4M | $179.0M | ||
| Q4 24 | $84.6M | $574.6M | ||
| Q3 24 | $-9.0M | $144.1M | ||
| Q2 24 | $67.4M | $169.7M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | — | ||
| Q3 25 | $78.3M | — | ||
| Q2 25 | $72.4M | — | ||
| Q1 25 | $54.6M | — | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $67.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 38.5% | — | ||
| Q1 25 | 30.7% | — | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 46.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.4% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.2% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 4.80× | ||
| Q3 25 | 2.49× | 2.40× | ||
| Q2 25 | 6.05× | 0.97× | ||
| Q1 25 | 22.92× | 2.81× | ||
| Q4 24 | 6.75× | 8.77× | ||
| Q3 24 | -0.96× | 2.36× | ||
| Q2 24 | 3.44× | 1.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
